National implementation of Watch-and-Wait in patients with rectal cancer
British Journal of Surgery · 2025
DOI: 10.1093/bjs/znaf040 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Surgery, 2025. Verfasst von Barbara M Geubels und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Rectal Neoplasms, Watchful Waiting. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: The Dutch Cancer Society.
Abstract (Originalsprache)
Introduction
Most reports on the outcome of Watch-and-Wait (W&W) in rectal cancer come from expert centres. This study reports on a broad implementation in the Netherlands. Material and Methods The process of W&W implementation is described and the outcome of patients in a W&W registry between 2004 and 2022 analysed (regrowth, metastases, survival, and organ preservation). Three equally sized chronological cohorts were compared to capture any differences during implementation over time.
Results
W&W was gradually implemented in 18 high-volume hospitals coordinated by a single expert centre. One thousand and eighty patients with a clinical good response after (chemo)radiotherapy were included, with a median follow-up of 42 months (95% c.i. 40 to 44). At first response evaluation, 45% had a clinical complete response (cCR) and 55% near-complete reponse (nCR). In patients with nCR, 75% eventually achieved cCR, 14% underwent local excision, 2% received additional contact X-ray brachytherapy, and 10% underwent total mesorectal excision (TME) for persistent residual disease. Three-year actuarial local regrowth incidence was 23%. Three-year organ preservation rate was 76%. The 3-year distant metastases rate and overall survival were 10% and 97%. There were no significant differences in 3-year local regrowth or distant metastases between the three consecutive cohorts. In the two more recent cohorts more patients underwent TME for residual disease (13% versus 3%), likely due to a more liberal inclusion of patients with nCR.
Conclusion
The results of W&W in rectal cancer patients in high-volume hospitals mirror those of expert centres.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
- GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
- Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Radiation Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
ORCID-Profile: Geerard L Beets
Förderung
- The Dutch Cancer Society
Zitieren
APA
Geubels, B. M., Grotenhuis, B. A., van den Esschert, A. J., Lambregts, D. M. J., Maas, M., Marijnen, C. A. M., Beets-Tan, R. G. H., Beets, G. L., & Dutch Watch-and-Wait consortium (2025). National implementation of Watch-and-Wait in patients with rectal cancer. British Journal of Surgery. https://doi.org/10.1093/bjs/znaf040
Vancouver
Geubels BM, Grotenhuis BA, van den Esschert AJ, Lambregts DMJ, Maas M, Marijnen CAM, et al. National implementation of Watch-and-Wait in patients with rectal cancer. British Journal of Surgery. 2025. doi:10.1093/bjs/znaf040
BibTeX
@article{Geubels2025,
author = {Geubels, Barbara M and Grotenhuis, Brechtje A and van den Esschert, Aart-Jan and Lambregts, Doenja M J and Maas, Monique and Marijnen, Corrie A M and Beets-Tan, Regina G H and Beets, Geerard L and Dutch Watch-and-Wait consortium, Dutch Watch-and-Wait consortium},
title = {National implementation of Watch-and-Wait in patients with rectal cancer},
journal = {British Journal of Surgery},
year = {2025},
doi = {10.1093/bjs/znaf040}
}
EUVIMED